Cargando…

Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data

Head and neck squamous cell carcinoma (HNSCC) is a disease with heterogeneous clinical behavior and response to therapies. Despite the introduction of multimodality treatment, 40–50% of patients with advanced disease recur. Therefore, there is an urgent need to improve the classification beyond the...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Cecco, Loris, Nicolau, Monica, Giannoccaro, Marco, Daidone, Maria Grazia, Bossi, Paolo, Locati, Laura, Licitra, Lisa, Canevari, Silvana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496244/ https://www.ncbi.nlm.nih.gov/pubmed/25821127

Ejemplares similares

Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
por: De Cecco, Loris, et al.
Publicado: (2017)

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
por: Bossi, Paolo, et al.
Publicado: (2017)

Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Locati, Laura D., et al.
Publicado: (2019)

Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
por: Locati, Laura Deborah, et al.
Publicado: (2022)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures
por: Serafini, Mara S., et al.
Publicado: (2020)

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
por: Alfieri, Salvatore, et al.
Publicado: (2020)

Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions
por: Carenzo, Andrea, et al.
Publicado: (2020)

An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer
por: Cavalieri, Stefano, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
por: Callari, Maurizio, et al.
Publicado: (2012)

Correction: Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues
por: Callari, Maurizio, et al.
Publicado: (2013)

The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
por: Colombo, Elena, et al.
Publicado: (2023)

Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC)
por: Locati, Laura D., et al.
Publicado: (2023)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project
por: Cavalieri, Stefano, et al.
Publicado: (2020)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
por: Argiris, Athanassios, et al.
Publicado: (2019)

Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus–Positive Oropharyngeal Carcinoma
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Prognostic Nutritional Index: an easy nutritional screening for patients with head and neck cancer?
por: Bossi, Paolo
Publicado: (2018)

Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak
por: Resteghini, Carlo, et al.
Publicado: (2020)

Metabolic Footprints and Molecular Subtypes in Breast Cancer
por: Cappelletti, Vera, et al.
Publicado: (2017)

Comment on ‘Impact of intra-arterial chemotherapy including internal carotid artery for advanced paranasal sinus cancers involving the skull base'
por: Bossi, Paolo, et al.
Publicado: (2015)

Current relevance of hypoxia in head and neck cancer
por: Bredell, Marius G., et al.
Publicado: (2016)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
por: Galbiati, Donata, et al.
Publicado: (2019)

Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype
por: Huang, Xiaoyan, et al.
Publicado: (2015)

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group
por: Klinghammer, Konrad, et al.
Publicado: (2022)

Quality Assessment in Supportive Care in Head and Neck Cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2019)

The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial–mesenchymal transition, and immune response
por: Devecchi, Andrea, et al.
Publicado: (2018)

Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
por: Pisani, Silvia, et al.
Publicado: (2022)

Molecular Tumor Subtypes of HPV-Positive Head and Neck Cancers: Biological Characteristics and Implications for Clinical Outcomes
por: Qin, Tingting, et al.
Publicado: (2021)

Bleeding complications in patients with squamous cell carcinoma of the head and neck
por: Bergamini, Cristiana, et al.
Publicado: (2021)

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Argiris, Athanassios, et al.
Publicado: (2017)

Comment on ‘Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer’
por: Bossi, Paolo, et al.
Publicado: (2018)

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
por: Machiels, Jean-Pascal H, et al.
Publicado: (2014)

Impact of biospecimens handling on biomarker research in breast cancer
por: De Cecco, Loris, et al.
Publicado: (2009)

Does HPV Subtype Predict Outcomes in Head and Neck Cancers?
por: Ziai, Hedyeh, et al.
Publicado: (2021)

New transcriptional-based insights into the pathogenesis of desmoplastic small round cell tumors (DSRCTs)
por: Negri, Tiziana, et al.
Publicado: (2017)

Identification of a gene expression driven progression pathway in myxoid liposarcoma
por: De Cecco, Loris, et al.
Publicado: (2014)

Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
por: De Cecco, Loris, et al.
Publicado: (2013)

Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy
por: Corino, Valentina D. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tt8ul7eflvtq7lp79vi36sru4u